- Home
- ACCD
ACCD
Accolade Inc.
as 11-22-2024 3:30pm EST
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | PLYMOUTH MEETING |
| Market Cap: | 281.1M | IPO Year: | 2020 |
| Target Price: | $9.04 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.04 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.08 - $15.36 | Next Earning Date: | 01-06-2025 |
| Revenue: | $441,028,000 | Revenue Growth: | 16.04% |
| Revenue Growth (this year): | 15.56% | Revenue Growth (next year): | 11.76% |
Stock Insider Trading Activity of Accolade Inc. (ACCD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Cavanaugh Robert N | ACCD | President | Nov 11 '24 | Sell | $3.64 | 214 | $778.53 | 199,146 | |
| Barnes Stephen H. | ACCD | Chief Financial Officer | Nov 11 '24 | Sell | $3.64 | 223 | $811.27 | 204,999 | |
| Cavanaugh Robert N | ACCD | President | Nov 1 '24 | Sell | $3.15 | 475 | $1,495.78 | 199,146 | |
| SINGH RAJEEV | ACCD | Chief Executive Officer | Nov 1 '24 | Sell | $3.15 | 1,545 | $4,865.21 | 794,574 | |
| Eskew Richard | ACCD | EVP General Counsel | Nov 1 '24 | Sell | $3.15 | 336 | $1,058.06 | 52,515 | |
| McHugh Colin | ACCD | Chief Accounting Officer | Nov 1 '24 | Sell | $3.15 | 448 | $1,410.75 | 55,528 | |
| Barnes Stephen H. | ACCD | Chief Financial Officer | Nov 1 '24 | Sell | $3.15 | 458 | $1,442.24 | 204,999 | |
| Cavanaugh Robert N | ACCD | President | Oct 16 '24 | Sell | $3.67 | 157 | $576.03 | 199,146 | |
| SINGH RAJEEV | ACCD | Chief Executive Officer | Oct 16 '24 | Sell | $3.67 | 385 | $1,412.57 | 794,574 | |
| Barnes Stephen H. | ACCD | Chief Financial Officer | Oct 16 '24 | Sell | $3.67 | 122 | $447.62 | 204,999 |
Latest Accolade Inc. News
ACCD Breaking Stock News: Dive into ACCD Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 days ago
Accolade To Present at Upcoming Investor Conferences
Simply Wall St.
24 days ago
Accolade And 2 Other Penny Stocks To Watch On US Exchanges
Zacks
a month ago
Accolade (ACCD) Loses -15.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
PR Newswire
a month ago
Accolade Welcomes Renalogic to Trusted Partner Ecosystem
Zacks
a month ago
Accolade (ACCD) Upgraded to Buy: Here's What You Should Know
Simply Wall St.
2 months ago
Accolade Second Quarter 2025 Earnings: Beats Expectations
GuruFocus.com
2 months ago
Accolade Inc (ACCD) Q2 2025 Earnings Call Transcript Highlights: Strong Revenue and Cash Flow ...
Thomson Reuters StreetEvents
2 months ago
Q2 2025 Accolade Inc Earnings Call
Compare ACCD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ACCD Accolade Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.